NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

NRX-1074 in Early Course Schizophrenia

Phase 2

Withdrawn

Conditions: Schizophrenia

Interventions: Drug: Placebo
Drug: NRX-1074

First Posted Date: 2015-11-11

Last Posted Date: 2016-02-05

Lead Sponsor: NYU Langone Health

Registration Number: NCT02603458

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
New York University Langone Medical Center/ Bellevue Hospital, New York, New York, United States

Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments

Not Applicable

Completed

Conditions: Opioid Dependence

Interventions: Behavioral: Strengths-based Case Management (SBCM)
Behavioral: Screening, Assessment, and Referral (SAR)

First Posted Date: 2015-10-27

Last Posted Date: 2020-05-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 300

Registration Number: NCT02586896

Locations: 🇺🇸
Bellevue Hospital Center, New York, New York, United States

Evaluation of Salt Sensitivity in Young Adults

Not Applicable

Completed

Conditions: Healthy Volunteers

Interventions: Dietary Supplement: Salt tablet

First Posted Date: 2015-10-27

Last Posted Date: 2016-05-19

Lead Sponsor: NYU Langone Health

Target Recruit Count: 40

Registration Number: NCT02588352

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Protocol for Staged Stereotactic Radiosurgery for Large Arteriovenous Malformations

Not Applicable

Completed

Conditions: Intracranial Arteriovenous Malformations (AVM)

Interventions: Procedure: Fractionated stereotactic radiosurgery
Device: Leskell gamma unit

First Posted Date: 2015-10-15

Last Posted Date: 2023-11-07

Lead Sponsor: NYU Langone Health

Target Recruit Count: 18

Registration Number: NCT02576535

Electrical Inhibition (EI): A Preliminary Study To Inhibit Preterm Labor And Preterm Birth

Phase 1

Withdrawn

Conditions: Premature Labor
Premature Birth

Interventions: Device: Electrical Inhibition (EI)

First Posted Date: 2015-10-06

Last Posted Date: 2017-11-09

Lead Sponsor: NYU Langone Health

Registration Number: NCT02569216

Locations: 🇺🇸
New York University Hospital, Manhattan, New York, United States

Implementing Tobacco Use Guidelines in Community Health Centers in Vietnam Public Health System

Not Applicable

Completed

Conditions: Tobacco Use Cessation

Interventions: Behavioral: Technical Assistance, training and clinical reminders
Behavioral: TTC+Referral to Community Health Worker

First Posted Date: 2015-10-01

Last Posted Date: 2020-06-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 4733

Registration Number: NCT02564653

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Understanding the Mechanism(s) of Action on the Modified Atkins Diet for Epilepsy: Human Brain Tissues

Not Applicable

Completed

Conditions: Epilepsy

Interventions: Other: Modified Atkins Diet (MAD)

First Posted Date: 2015-10-01

Last Posted Date: 2020-01-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 19

Registration Number: NCT02565966

Locations: 🇺🇸
NYU Langone Epilepsy Center, New York, New York, United States
🇺🇸
Institute of Neurology and Neurosurgery at Saint Barnabas, Livingston, New Jersey, United States

Antiplatelet Therapy in HIV

Phase 2

Completed

Conditions: HIV
Cardiovascular Diseases
Inflammation

Interventions: Drug: Aspirin
Drug: Clopidogrel

First Posted Date: 2015-09-24

Last Posted Date: 2018-10-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 55

Registration Number: NCT02559414

Locations: 🇺🇸
Bellevue Hospital, New York, New York, United States
🇺🇸
NYU Langone Medical Center, New York, New York, United States

Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study

Early Phase 1

Completed

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Drug: Placebo
Drug: Azithromycin

First Posted Date: 2015-09-23

Last Posted Date: 2019-03-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 19

Registration Number: NCT02557958

Optic Nerve Head Quantification While Reducing Elevated Intracranial Pressure

Withdrawn

Conditions: Intracranial Hypertension
Intraocular Pressure

First Posted Date: 2015-09-23

Last Posted Date: 2017-01-12

Lead Sponsor: NYU Langone Health

Registration Number: NCT02558309

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy